Open-Source LLMs Promote AI Health Equity, Study Finds

According to a preprint posted on ResearchGate (October 2025), the paper titled "Open-Source Large Language Models and AI Health Equity: A Health Service Triangle Model Perspective" analyzes the potential role of open-source LLMs in promoting AI health equity. The preprint reports that closed-source models contribute to global application inequalities by creating technological monopolies, imposing high operational costs, and raising data-privacy barriers. The authors compare open-source and closed-source models across parameter scale, deployment methods, and application scenarios and report that open-source models enable local deployment, facilitate secondary development, and provide cost advantages for health-service delivery.

The preprint frames its evaluation using the health service triangle model, and explicitly compares model attributes such as parameter scale and deployment modality as part of that framework. Per the ResearchGate record, the authors highlight local deployment and secondary development as technical benefits of open-source stacks for low-resource settings. The paper also flags well-known model risks, listing hallucination and ethical-responsibility challenges as limitations that must be managed.

Editorial analysis: Open-source model ecosystems often reduce vendor lock-in and lower barriers to customization and deployment, which can matter for health providers that must operate under constrained budgets, intermittent connectivity, and strict data-governance rules. Observers note a consistent pattern where local deployment reduces data egress concerns and enables fine-grained adaptation to population-specific clinical language and workflows.

Editorial analysis: For the AI-for-health community, the preprint contributes to an ongoing debate on whether open-source LLMs materially improve equity in health AI adoption. The paper adds a structured conceptual lens (the health service triangle) to that debate, but its conclusions are drawn from comparative argumentation rather than large-scale deployment evidence. That distinction matters for practitioners assessing risk and compliance trade-offs in clinical settings.

• •Observational studies or pilot deployments that quantify outcomes (accuracy, safety, cost) for locally deployed open-source stacks.
• •Published benchmarks or benchmarks tailored to clinical tasks comparing open-source and closed-source model performance and calibration.
• •Community-driven toolkits for hallucination mitigation and regulatory-compliant auditing for local deployments.
• •Peer review or formal publication of the preprint and any follow-on replication studies.

The preprint is a conceptual contribution advocating that open-source LLMs can support democratization of medical resources, while cautioning about known technical and ethical limitations. Its value to practitioners is in framing deployment trade-offs and research directions rather than supplying production-ready evidence.